Gao Xiang, Gu Zhuoqi, Huang Yuankai, Li Haotao, Xi Xiaoyu
The Research Center of National Drug Policy & Ecosystem, China Pharmaceutical University, No.639 Longmian Avenue, Jiangning District, Nanjing, Jiangsu Province, China.
Heliyon. 2024 Jul 26;10(19):e35192. doi: 10.1016/j.heliyon.2024.e35192. eCollection 2024 Oct 15.
This study aimed to understand the current status of pharmaceutical care barriers perceived by clinical pharmacists in secondary and tertiary hospitals in China, and to provide a reference for further improving the quality of pharmaceutical care and perfecting the construction of pharmaceutical care system in China.
The PCBS-CH scale (Pharmaceutical Care Barriers Scale in Chinese Hospitals) was used to measure the perceived pharmaceutical care barriers of clinical pharmacists, and descriptive statistical analysis was used to identify the main barriers faced by clinical pharmacists. The different barriers perceived by clinical pharmacists with various characteristics was investigated by subgroup analysis.
A total of 1266 clinical pharmacists from 31 provinces were finally included. The results revealed that the main barriers faced by clinical pharmacists in the process of implementing pharmaceutical care included lack of additional staffing, lack of time for pharmaceutical care provision and continuing education, and lack of an electronic information system and prescription evaluation system for pharmaceutical care. Subgroup analysis found that clinical pharmacists who are without training (P < 0.001), worked in tertiary hospitals (P = 0.036), and had other training certificates (P < 0.001) perceived higher pharmaceutical care barriers.
Clinical pharmacists in secondary and tertiary hospitals in China have a low perception of overall pharmaceutical care barriers, but still face some important barriers. In order to promote the development of pharmaceutical care in China, the quality of clinical pharmacists should be improved, strict entry criteria should be established, clear responsibilities should be defined, the rights of female clinical pharmacists should be protected, and hospital facilities should be upgraded.
本研究旨在了解中国二级和三级医院临床药师所感知的药学服务障碍现状，为进一步提高中国药学服务质量和完善药学服务体系建设提供参考。
采用中国医院药学服务障碍量表（PCBS-CH）来衡量临床药师所感知的药学服务障碍，并使用描述性统计分析来确定临床药师面临的主要障碍。通过亚组分析调查具有不同特征的临床药师所感知的不同障碍。
最终纳入了来自31个省份的1266名临床药师。结果显示，临床药师在实施药学服务过程中面临的主要障碍包括缺乏额外人员配置、缺乏提供药学服务和继续教育的时间，以及缺乏药学服务的电子信息系统和处方评估系统。亚组分析发现，未接受过培训的临床药师（P < 0.001）、在三级医院工作的临床药师（P = 0.036）以及拥有其他培训证书的临床药师（P < 0.001）所感知的药学服务障碍更高。
中国二级和三级医院的临床药师对整体药学服务障碍的感知较低，但仍面临一些重要障碍。为促进中国药学服务的发展，应提高临床药师素质，建立严格的准入标准，明确职责，保护女性临床药师权利，并升级医院设施。
